English Deutsch 中文
  • Innovative Solutions
  • Expert Support and Knowledge
  • Reliable Cooperation
Menu Deutsch 中文

Pfizer's China Swine Vaccine Unit Sold To Harbin Pharmaceutical Group

May. 28, 2010

Pfizer Inc is said to have sold its swine vaccine unit in China to Harbin Pharmaceutical Group.
According the report, Pfizer will sell its RespiSure and RespiSure-One swine mycoplasma hyopneumoniae (MH) vaccines to Harbin Bio-Vaccine, an animal health unit of Harbin Pharmaceutical for US$ 50 million.
Pfizer is required to divest its swine flu business in China as a condition by the Chinese antitrust authorities for Pfizer’s last year $68 billion merger with Wyeth.
Harbin Pharmaceutical, which counts Warburg Pincus among its major shareholders, manufactures and distributes generic antibiotics in China.